Find a Clinical Trial

Showing 1 - 6 out of 6

HGB-210

A Phase 3 Study Evaluating Gene Therapy by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo with the LentiGlobin BB305 Lentiviral Vector in Subjects with Sickle Cell Disease.

Sickle cell anemia

All genders

2-50

Recruiting now

Department of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Cancer Center

Tufts Medical Center

Learn more

ANHL1931

ANHL1931: A Randomized Phase 3 trial of Nivolumab in Combination with Chemo-immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-cell Lymphoma

Lymphoma

All genders

Recruiting now

Department of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Cancer Center

Tufts Medical Center

Learn more

ROACTIVE-HF II

Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor
System in New York Heart Association (NYHA) Class II-III Heart Failure Patients
(PROACTIVE-HF-2 Trial)

Heart failure

All genders

18+

Recruiting now

Division of Cardiology

Tufts Medical Center

Learn more

OCS Heart Perfusion Registry

OCS Heart Perfusion Post- Approval Registry

Heart transplantation

All genders

18+

Recruiting now

CardioVascular Center

Tufts Medical Center

Learn more

Wound Healing and Recovery after Surgery Using AI

Predicting Wound Healing and Recovery after Surgery Using Artificial Intelligence

All genders

18-100

Recruiting now

Department of Surgery

Tufts Medical Center

Learn more

Pulmonary vascular impedance in cardiogenic shock

Pulmonary vascular impedance as a novel tool to understand right ventricular afterload in cardiogenic shock

Heart failure, Shock

All genders

18+

Recruiting now

CardioVascular Center

Tufts Medical Center

Learn more

Find Care

Services + Treatments

Patients + Visitors

Research + Academics

Clinicians

Find a Clinical Trial

Filter

A Phase 3 Study Evaluating Gene Therapy by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo with the LentiGlobin BB305 Lentiviral Vector in Subjects with Sickle Cell Disease.

ANHL1931: A Randomized Phase 3 trial of Nivolumab in Combination with Chemo-immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-cell Lymphoma

Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor
System in New York Heart Association (NYHA) Class II-III Heart Failure Patients
(PROACTIVE-HF-2 Trial)

OCS Heart Perfusion Post- Approval Registry

Predicting Wound Healing and Recovery after Surgery Using Artificial Intelligence

Pulmonary vascular impedance as a novel tool to understand right ventricular afterload in cardiogenic shock

Find Care

Services + Treatments

Patients + Visitors

Research + Academics

Clinicians

Find a Clinical Trial

Filter

A Phase 3 Study Evaluating Gene Therapy by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo with the LentiGlobin BB305 Lentiviral Vector in Subjects with Sickle Cell Disease.

ANHL1931: A Randomized Phase 3 trial of Nivolumab in Combination with Chemo-immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-cell Lymphoma

Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class II-III Heart Failure Patients (PROACTIVE-HF-2 Trial)

OCS Heart Perfusion Post- Approval Registry

Predicting Wound Healing and Recovery after Surgery Using Artificial Intelligence

Pulmonary vascular impedance as a novel tool to understand right ventricular afterload in cardiogenic shock

Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor
System in New York Heart Association (NYHA) Class II-III Heart Failure Patients
(PROACTIVE-HF-2 Trial)